The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury

• Zubair Ahmed,
• Richard I. Tuxworth

Affiliations

Zubair Ahmed

Neuroscience and Ophthalmology, Institute of Inflammation and Ageing University of Birmingham Birmingham UK

Richard I. Tuxworth

Centre for Trauma Sciences Research University of Birmingham Birmingham UK